Acute Kidney Injury in Dogs and Cats: Emergency-Care Module
Clinical aim: identify reversible prerenal and postrenal disease immediately, stabilize ABCs, stop ongoing renal injury, measure urine output accurately, correct life-threatening electrolyte and acid-base abnormalities, and avoid fluid overload.
AKI is not synonymous with azotaemia. A patient can have substantial acute renal tubular injury before creatinine rises. Serial trends and urine output matter. IRIS grades AKI I-V using creatinine plus clinical features and urine flow, but grading does
not replace identifying the cause. See the current
IRIS AKI framework and the 2024
IRIS dialysis guideline.
1. BASIC UNDERSTANDING
Definition
Acute kidney injury (AKI) is an abrupt decline in renal function causing decreased GFR, impaired tubular function, and variable oliguria, anuria, polyuria, azotaemia, electrolyte/acid-base derangements, and uraemic illness.
It may be:
- Prerenal: reduced renal perfusion, kidneys initially structurally intact.
- Intrinsic renal: direct nephron injury.
- Postrenal: impaired urine outflow, urine leakage, or obstruction.
- Acute-on-chronic kidney disease: an acute insult in a patient with pre-existing CKD.
Species affected
Both dogs and cats.
Important species differences:
- Cats: ureteral obstruction, ureterolithiasis, lily toxicity, and pyelonephritis are particularly important.
- Dogs: leptospirosis, ethylene glycol toxicity where relevant geographically, severe heat injury, infectious/inflammatory disease, and drug/toxin exposure are common concerns.
Predisposition
There is no single sex or breed predisposition to AKI overall. Predisposition is cause-specific:
| Predisposing situation | Higher-risk patients |
|---|
| Leptospirosis | Unvaccinated or incompletely vaccinated dogs, outdoor/rodent-exposed dogs, endemic areas |
| Ureteral obstruction | Cats, especially with calcium oxalate ureteroliths |
| Nephrotoxic injury | Hospitalized, hypotensive, dehydrated, septic, geriatric, or pre-existing CKD patients |
| Lily toxicosis | Cats only. Any suspected ingestion is an emergency |
| NSAID-associated AKI | Dehydrated, hypotensive, CKD, geriatric, anaesthetized, or concurrently nephrotoxin-exposed patients |
| Ischaemic injury | Shock, haemorrhage, sepsis, heatstroke, pancreatitis, anaesthesia-related hypotension |
Epidemiology and major causes
Prerenal causes
- Vomiting, diarrhoea, poor intake
- Haemorrhage
- Shock, sepsis, anaphylaxis
- Severe dehydration
- Reduced effective circulating volume: severe cardiac disease, third spacing
- Hypotension under anaesthesia
Intrinsic renal causes
- Ischaemic acute tubular injury
- Nephrotoxins: NSAIDs, aminoglycosides, radiographic contrast in at-risk patients, grapes/raisins in dogs, lilies in cats, ethylene glycol, vitamin D/cholecalciferol products
- Infectious: leptospirosis, pyelonephritis, bacterial sepsis
- Pigment nephropathy: haemoglobinuria/myoglobinuria
- Glomerular, vascular, interstitial, infiltrative, or immune-mediated disease
- Hypercalcaemia
Postrenal causes
- Urethral obstruction
- Bilateral ureteral obstruction, or unilateral obstruction in a solitary functioning kidney
- Uroabdomen
- Urolithiasis, strictures, neoplasia, blood clots
- Iatrogenic ureteral ligation or trauma
Pathogenesis: step-by-step
- Initial insult reduces perfusion, directly injures tubular cells, or prevents urine leaving the urinary tract.
- GFR falls because renal perfusion falls, intratubular pressure rises, or nephrons are damaged.
- Tubular dysfunction develops. Tubules cannot reabsorb water, sodium, bicarbonate, and nutrients normally, or excrete potassium, acids, phosphorus, and waste products.
- Azotaemia and uraemia develop. Urea and creatinine rise, but creatinine may lag 24-48 hours behind injury.
- Electrolyte and acid-base abnormalities develop. Hyperkalaemia, hyperphosphataemia, metabolic acidosis, and sometimes hypocalcaemia are common in severe low-output AKI.
- Systemic consequences follow: nausea, vomiting, anorexia, GI mucosal injury, weakness, hypertension or hypotension, arrhythmias, pulmonary oedema if fluid overloaded, and neurologic signs in severe uraemia.
- Recovery is possible if surviving nephrons regain function. Recovery is often polyuric, so dehydration and hypokalaemia may then become major risks.
Simple concept: damaged kidneys either cannot filter, cannot concentrate, cannot regulate electrolytes, or cannot eliminate toxins. In oliguric AKI, adding more fluid does not “wash out” damaged kidneys. It can cause pulmonary oedema. “Fluid dena hai, but fluid overload nahi karna.”
Why the signs occur
| Clinical sign | Why it happens |
|---|
| Lethargy, weakness | Uraemia, dehydration, acidosis, anaemia if chronic component, electrolyte disorders |
| Vomiting, nausea, hypersalivation | Uraemic toxins, gastritis, altered GI motility |
| Anorexia | Nausea, altered taste, uraemia, pain |
| PU/PD | Tubular dysfunction and inability to concentrate urine, especially during recovery |
| Oliguria/anuria | Markedly decreased GFR, obstruction, or severe renal injury |
| Halitosis/oral ulcers | Uraemic mucosal injury |
| Bradycardia/arrhythmia | Hyperkalaemia |
| Tachypnoea | Metabolic acidosis, pain, pulmonary oedema, or concurrent disease |
| Hypertension | RAAS activation, sodium/water handling abnormalities, pain/stress |
| Oedema/serous effusion | Fluid overload, hypoalbuminaemia, severe renal dysfunction |
2. HISTORY TAKING: CLINIC CHECKLIST
Immediate triage questions
Ask these before a long history:
- Is the patient producing urine? When was the last normal urination?
- Is there repeated straining with little or no urine?
- Has there been sudden collapse, profound weakness, slow heart rate, or dyspnoea?
- Could the cat have accessed lilies?
- Could the dog have eaten grapes/raisins, antifreeze, rodenticide, human medication, or unknown chemicals?
- Has there been NSAID, aminoglycoside, chemotherapy, contrast, or anaesthetic exposure?
- Is leptospirosis possible? Rodents, stagnant water, wildlife, farm exposure, local outbreaks?
Ready-to-use owner history checklist
Presenting complaint and time course
- What changed first: vomiting, anorexia, reduced urine, increased drinking, lethargy, collapse?
- Exact onset and rate of progression?
- Sudden onset or chronic weight loss/PU-PD before this illness?
- Any previous abnormal renal values or diagnosis of CKD?
Appetite, water, urine, faeces
- Appetite: reduced, absent, selective, painful swallowing?
- Water intake: increased, reduced, or unable to keep water down?
- Urination: frequency, volume, straining, dysuria, haematuria, inappropriate urination, last confirmed urine?
- Defecation: diarrhoea, melaena, constipation?
- Vomiting: frequency, blood/coffee-ground material, relation to food?
- Estimate fluid loss: vomiting/diarrhoea frequency and volume.
Systemic signs
- Lethargy, weakness, collapse, tremors, seizures?
- Cough, tachypnoea, or exercise intolerance?
- Fever, pain, lameness, jaundice?
- Weight loss, chronic PU/PD, poor coat?
Exposure history
- Any access to:
- Lilies, grapes/raisins, antifreeze, vitamin D products?
- Human painkillers, especially NSAIDs?
- Rat poisons, pesticides, chemicals?
- Contaminated water, rodents, wildlife, farms?
- Tick/flea exposure and travel?
- Boarding, shelter, new pets, dog parks?
- Trauma, pelvic injury, recent surgery?
Previous medical and medication history
- CKD, heart disease, diabetes, hyperthyroidism, pancreatitis, pyometra, urinary stones, FLUTD?
- Recent hospitalisation or anaesthesia?
- Medication name, strength, dose, frequency, last dose:
- NSAIDs
- ACE inhibitors/ARBs
- Diuretics
- Aminoglycosides
- Chemotherapy
- Steroids
- Supplements/herbals
- Vaccination status, especially Leptospira vaccination in dogs.
- Deworming and parasite control.
- Reproductive history if relevant: intact female with possible pyometra; pregnancy/lactation.
3. CLINICAL EXAMINATION
Triage first: ABC
- Airway: patency, mentation, vomiting/aspiration risk.
- Breathing: respiratory rate/effort, crackles, oxygen saturation, pulmonary oedema.
- Circulation: heart rate/rhythm, pulses, blood pressure, mucous membranes, CRT, temperature.
Specific examination findings
| Area | What to assess | AKI significance |
|---|
| TPR | Fever, hypothermia, tachycardia, bradycardia, tachypnoea | Fever may suggest pyelonephritis/leptospirosis/sepsis; bradycardia may signal hyperkalaemia; hypothermia is a poor perfusion/sepsis marker |
| Mucous membranes/CRT | Pale, injected, tacky, dry, uremic ulcers; CRT | Dehydration/hypoperfusion, anaemia, shock, uraemic oral disease |
| Hydration | Skin tent, tacky gums, globe position, body weight | Estimate deficit but do not rely on skin turgor alone in geriatric/obese animals |
| Body condition/muscle mass | Cachexia, muscle wasting, obesity | Muscle wasting may falsely lower creatinine; chronic wasting supports CKD or chronic disease |
| Cardiovascular | HR/rhythm, pulse quality, BP, jugular distension | Hypotension worsens AKI; hypertension causes retinal/CNS injury; arrhythmia suggests hyperkalaemia |
| Respiratory | Crackles, increased effort, SpO₂ | Suspect fluid overload, aspiration, pulmonary oedema, acidosis |
| Abdomen | Kidney size/pain, bladder size, pain, free fluid | Enlarged painful kidneys: AKI/pyelonephritis/infiltration; small irregular kidneys: CKD; large firm bladder: obstruction; free fluid: uroabdomen |
| Urogenital | Penis/prepuce/vulva, urethra, perineum | Look for obstruction, trauma, discharge |
| Neurologic | Mentation, weakness, tremors, seizures | Uraemic encephalopathy, hypertension, hypocalcaemia, toxins |
| Eyes | Fundic exam, retinal haemorrhage/detachment | Hypertensive emergency |
| Oral cavity | Ulcers, halitosis, dehydration | Uraemia; also check for caustic toxin injury |
| Skin | Oedema, petechiae, dehydration, toxin contamination | Fluid overload, coagulopathy, exposure clues |
| Lymph nodes | Enlargement | Infection, neoplasia, systemic inflammation |
Pain assessment
Look for:
- Renal palpation pain
- Abdominal guarding
- Tense posture
- Hunched stance
- Vocalisation
- Hypertension/tachycardia from pain
Use validated pain scoring where possible. Avoid NSAIDs in suspected AKI.
4. DIFFERENTIAL DIAGNOSIS
The emergency rule
Before calling a patient “renal AKI,” rule out:
- Hypovolaemia/shock
- Urinary obstruction
- Uroabdomen
- Hyperkalaemia
- Sepsis/leptospirosis
- Toxin exposure
Azotaemia comparison
| Feature | Prerenal azotaemia | Intrinsic renal AKI | Postrenal azotaemia |
|---|
| Main problem | Reduced renal perfusion | Nephron injury | Urine cannot exit normally |
| Volume status | Often dehydrated/hypovolaemic | Variable | Variable |
| USG | Often concentrated if tubular function intact | Often inadequately concentrated | Variable |
| Response to rehydration | Rapid improvement if pure prerenal | Persists or worsens | Persists until obstruction/leak is corrected |
| Urine output | Often low initially | Low, normal, or high | Often low/anuric, stranguria may occur |
| Imaging | Usually normal | May show renomegaly, altered architecture | Dilated renal pelves/ureters, distended bladder, effusion |
| Key treatment | Restore perfusion | Treat cause + supportive care | Decompress/repair obstruction or leak |
Important and life-threatening differentials
| Differential | Clinical clues | Key tests/findings |
|---|
| Urethral obstruction | Stranguria, repeated litter-box visits, painful distended bladder, hyperkalaemic bradycardia | Palpation, POCUS, ECG, potassium |
| Bilateral ureteral obstruction | Cat with acute anorexia/vomiting, small or normal bladder, painful kidneys | Ultrasound: pyelectasia/hydroureter; CT/contrast studies if needed |
| Uroabdomen | Trauma/surgery, abdominal distension, shock, oliguria | Effusion creatinine and potassium higher than serum |
| Leptospirosis | Fever, vomiting, AKI with hepatic or pulmonary involvement, exposure risk | PCR/serology paired with clinical context |
| Pyelonephritis | Fever, renal pain, pyuria/bacteriuria, systemic inflammation | Urine culture before antibiotics, ultrasound |
| Ethylene glycol | Neurologic signs early, severe acidosis, calcium oxalate monohydrate crystals may occur | Exposure history, acid-base status, toxin assay where available |
| Lily toxicosis | Any cat with possible lily exposure | Treat as emergency before confirmatory evidence |
| NSAID nephrotoxicity | Medication access/overdose, dehydration or concurrent risk | Drug history, GI injury, AKI trend |
| Acute-on-CKD | Prior PU/PD/weight loss, small irregular kidneys, chronic non-regenerative anaemia | Previous labs, imaging, chronicity markers |
| Addisonian crisis | Weakness, vomiting, bradycardia, hyperkalaemia, hyponatraemia | Electrolyte pattern, ACTH stimulation testing after stabilization |
| Pancreatitis/sepsis | Pain, vomiting, hypotension, inflammation | Imaging, Spec cPL/fPL as clinically indicated, cultures/source investigation |
5. CBC INTERPRETATION
CBC changes in AKI are usually nonspecific. They identify complications and causes rather than confirm AKI.
| Parameter | Possible AKI-associated finding | Clinical meaning |
|---|
| PCV/HCT, Hb, RBC | Increased with dehydration; decreased with haemorrhage, chronic kidney disease, inflammation, haemolysis | Hemoconcentration may mask anaemia. Low HCT on presentation can indicate chronicity, bleeding, or severe inflammatory disease |
| MCV/MCHC | Usually normal | Macrocytosis/hypochromasia suggests regeneration; microcytosis may suggest iron deficiency/chronic blood loss |
| Reticulocytes | Often low if CKD-associated anaemia; high if haemorrhage/haemolysis | True AKI alone does not immediately create marked erythropoietin-deficiency anaemia |
| WBC/neutrophils | Neutrophilia, left shift, toxic change with infection/sepsis | Supports pyelonephritis, leptospirosis, pancreatitis, tissue injury, sepsis |
| Neutropenia | Consumption/sepsis | Grave finding if accompanied by toxic change and instability |
| Lymphocytes | Lymphopenia common with stress | Nonspecific. Lymphocytosis can occur with hypoadrenocorticism |
| Monocytes | Monocytosis in inflammation/stress | Supports inflammatory disease but is nonspecific |
| Eosinophils | Eosinophilia may support hypoadrenocorticism or parasites | Interpret with clinical context |
| Platelets | Thrombocytopenia in sepsis, DIC, leptospirosis, immune-mediated disease | Confirm with blood smear because clumping is common, especially in cats |
Pattern recognition
- Regenerative anaemia: reticulocytosis, polychromasia, anisocytosis. Think bleeding or haemolysis.
- Non-regenerative anaemia: inadequate reticulocyte response. CKD, chronic inflammation, marrow disease.
- Left shift: increased immature neutrophils. Indicates high tissue demand/inflammation.
- Toxic neutrophils: accelerated marrow release, commonly severe inflammation/sepsis.
- Neutrophilia: stress, inflammation, steroid effect, infection.
- Neutropenia with toxic change: potentially overwhelming sepsis.
- Thrombocytopenia: verify manually, then consider leptospirosis, DIC, sepsis, immune destruction.
6. SERUM BIOCHEMISTRY AND BLOOD GAS INTERPRETATION
Core AKI pattern
| Parameter | Expected change | Mechanism and importance |
|---|
| BUN/urea | Increased | Reduced filtration, catabolism, GI bleeding, dehydration. Less specific than creatinine |
| Creatinine | Increased or rising serially | Reduced GFR. May initially be normal after acute insult; affected by muscle mass |
| SDMA | Increased | Reduced GFR; may rise earlier than creatinine, but interpret trends and assay/lab context |
| Phosphorus | Increased | Reduced excretion. Severe hyperphosphataemia suggests severe reduction in GFR/cell injury |
| Potassium | High in oliguric/anuric AKI or obstruction; low in recovery/polyuric phase | Hyperkalaemia can cause fatal arrhythmia. Hypokalaemia worsens weakness and renal tubular function |
| Sodium/chloride | Variable | Vomiting, fluid type, obstruction, adrenal disease, renal losses all influence values |
| Bicarbonate/total CO₂ | Often decreased | Metabolic acidosis from reduced acid excretion and poor perfusion |
| Anion gap | Often increased | Retained acids, lactate, uraemic toxins |
| Calcium | Total calcium variable; ionised calcium may be low/normal/high | Interpret ionised calcium when clinically relevant. Hypercalcaemia can cause AKI and must be investigated |
| Albumin/total protein | High with dehydration; low with protein loss, inflammation, effusion | Helps assess hydration and concurrent disease |
| ALT/AST/ALP/GGT/bilirubin | Variable | May point toward leptospirosis, hypoperfusion, hepatobiliary disease, pancreatitis, haemolysis |
| Glucose | High with stress; low with sepsis or severe hepatic disease | Hypoglycaemia is an emergency clue in septic/toxic patients |
| Cholesterol/triglycerides | Variable | Not primary AKI markers; may support protein-losing or endocrine disease |
| Amylase/lipase | May increase with reduced renal clearance | Do not diagnose pancreatitis from nonspecific increases alone |
| Spec cPL/fPL | Use only when pancreatitis is a meaningful differential | Interpret with imaging and clinical signs |
Hyperkalaemia: immediate interpretation
Obtain an ECG if potassium is significantly high, rising, or patient is bradycardic/weak.
Potential ECG changes:
- Tall tented T waves
- Shortened QT
- Prolonged PR
- QRS widening
- Loss of P waves
- Ventricular arrhythmias or sine-wave pattern
Treat the patient and ECG, not a single potassium value alone.
Blood gas and lactate
- Venous blood gas: pH, bicarbonate, base excess, potassium, ionised calcium.
- Lactate: perfusion marker, not a direct renal marker.
- Severe metabolic acidaemia requires cause-directed treatment. Bicarbonate is not routine for every AKI patient.
7. URINALYSIS
Collect urine before antimicrobial therapy whenever feasible, but never delay life-saving stabilization for sampling.
| UA element | AKI relevance |
|---|
| USG | Inappropriately low USG in an azotaemic patient supports renal dysfunction, but early AKI may still have concentrated urine |
| pH | Variable; alkaline urine with pyuria/bacteriuria can support infection but is not diagnostic |
| Protein | May reflect tubular injury, glomerular disease, inflammation, haematuria, or infection. Interpret UPC only after sediment is inactive |
| Glucose | Normoglycaemic glucosuria supports proximal tubular dysfunction, for example Fanconi syndrome or toxic tubular injury |
| Ketones | Consider diabetic ketoacidosis, starvation, or severe illness |
| Blood/RBCs | Trauma, cystocentesis, stones, infection, obstruction, neoplasia, pigment |
| WBCs | Pyuria supports inflammation/infection but is not synonymous with bacterial UTI |
| Bacteria | Confirm with culture. Consider contamination, especially with voided samples |
| Casts | Granular casts and renal tubular epithelial cell casts support tubular injury; absence does not exclude AKI |
| Crystals | Calcium oxalate monohydrate may support ethylene glycol exposure; calcium oxalate/uroliths may support obstruction. Crystalluria alone is not diagnostic |
| Bilirubin | Small amounts can be normal in concentrated canine urine; interpret cautiously, especially in cats |
| Sediment | “Active” sediment may indicate pyelonephritis, urolithiasis, haemorrhage, or inflammation |
Important clinical cautions
- USG cannot by itself distinguish AKI from CKD.
- Collect urine for culture and susceptibility when pyelonephritis is possible.
- UPC is best deferred until haematuria, pyuria, bacteriuria, and marked postrenal protein contamination are controlled.
- A normal urine sediment does not exclude AKI.
8. PRACTICAL DIAGNOSTIC PLAN
First 5-15 minutes
- ABC assessment.
- Place IV catheter, obtain blood and urine samples if this does not delay stabilization.
- Check:
- Bedside glucose
- PCV/TS
- Electrolytes, especially potassium
- Blood gas/acid-base if available
- Blood pressure
- ECG if hyperkalaemia/bradycardia
- Palpate bladder and kidneys.
- POCUS: bladder size, free abdominal fluid, renal pelvis dilation, lung B-lines/effusion.
Minimum database
- CBC with smear review
- Serum biochemistry: BUN, creatinine, phosphorus, electrolytes, calcium, albumin, glucose, liver values
- Blood gas and lactate in ill patients
- Urinalysis with sediment and USG
- Blood pressure
- Accurate body weight
- Urine output measurement
- ECG if hyperkalaemic, bradycardic, or unstable
Recommended tests
- Urine culture and susceptibility, ideally cystocentesis sample
- Abdominal ultrasound
- Abdominal radiographs
- Serial creatinine, BUN, phosphorus, potassium, acid-base values
- UPC after sediment is inactive if proteinuria persists
- Leptospira PCR/serology as appropriate
- Spec cPL/fPL when pancreatitis is plausible
- Toxicology testing when it changes management
- Coagulation testing if bleeding/DIC is possible
Severe/emergency tests
- ECG and continuous rhythm monitoring
- Serial blood gases/electrolytes
- Thoracic radiographs or lung ultrasound if fluid overload is suspected
- Abdominocentesis if free fluid is present:
- Compare abdominal-fluid creatinine and potassium with serum for uroabdomen
- Crossmatch/type if transfusion could be required
- Blood cultures when bacteraemia/sepsis is a credible concern, ideally before antibiotics
Confirmatory approach
AKI is generally a clinical diagnosis based on abrupt renal dysfunction, serial changes, urine output, and exclusion of prerenal/postrenal causes. There is no single definitive AKI test.
9. IMAGING
Radiography
Recommended views
- Abdominal right lateral
- Abdominal left lateral
- Ventrodorsal or dorsoventral view
Look for
- Renal size and shape
- Radiopaque uroliths
- Bladder distension
- Loss of abdominal serosal detail suggesting effusion
- Prostatic enlargement, masses, trauma
- Mineralized ureteral calculi, though many are not visible
Radiographs are limited for ureteral obstruction and renal parenchymal disease.
Ultrasound
Use early when obstruction, pyelonephritis, nephrolithiasis, renal size change, mass, or uroabdomen is suspected.
Possible AKI findings:
- Renomegaly
- Increased cortical echogenicity
- Medullary rim sign, nonspecific
- Pyelectasia/hydronephrosis
- Hydroureter
- Renal/ureteral calculi
- Perirenal fluid
- Irregular renal contour or small kidneys, supporting chronic disease
- Renal pelvic debris in pyelonephritis, but not diagnostic alone
Important: normal ultrasound does not exclude AKI or pyelonephritis. Pyelectasia can be physiologic, especially after fluid therapy. Interpret with clinical context and serial imaging.
CT
Useful for:
- Suspected ureteral obstruction not fully characterized by ultrasound/radiographs
- Complex stone mapping
- Surgical/interventional planning
- Renal/ureteral anomalies or masses
Use contrast cautiously and only when benefit outweighs risk. Avoid assuming contrast is harmless in unstable AKI.
Echocardiography
Not a renal diagnostic test, but useful when:
- Fluid intolerance is suspected
- Cardiac disease complicates resuscitation
- Hypertension, pulmonary oedema, or shock is present
MRI
Rarely required for primary AKI. Use for neurologic complications or specific infiltrative/vascular questions.
10. DIAGNOSIS
Presumptive AKI
A sudden onset of compatible illness plus:
- Rising creatinine and/or SDMA
- Reduced urine production or tubular dysfunction
- Inappropriate urine concentration in an azotaemic patient
- Supportive urine sediment/imaging
- Compatible exposure or systemic disease
Definitive cause-based diagnosis
Examples:
- Urethral obstruction: clinical exam plus catheterization/imaging.
- Uroabdomen: abdominal fluid creatinine and potassium exceed serum values.
- Pyelonephritis: compatible illness plus urine culture, ideally with imaging support.
- Leptospirosis: appropriate PCR/serology plus clinical context.
- Toxin exposure: credible exposure history, compatible findings, or assay.
- Ureteral obstruction: ultrasound/CT/interventional findings.
IRIS AKI grading
After hydration status and postrenal obstruction are addressed, IRIS grades AKI I-V using creatinine, serial change, and clinical parameters including urine output. Broadly:
- Grade I: non-azotaemic AKI with documented renal injury or a relevant rising creatinine trend.
- Grades II-V: increasing severity of azotaemia.
- Subcategorize as oliguric, non-oliguric, or anuric, and identify need for renal replacement therapy.
Use the current
IRIS AKI resource, rather than relying on a single creatinine measurement.
Conflicting results
- High creatinine plus dehydration: may be prerenal, AKI, CKD, or mixed. Reassess after controlled rehydration.
- Normal creatinine with poor urine output: early AKI, low muscle mass, or obstruction remains possible.
- Concentrated urine: does not exclude early intrinsic AKI.
- Dilute urine: may result from fluids, diuretics, endocrine disease, CKD, or AKI.
- Small kidneys plus abrupt deterioration: acute-on-CKD is likely.
- Azotaemia improves after unblocking: postrenal component was present, but renal injury can persist.
Common diagnostic mistakes
- Calling all azotaemia “kidney failure.”
- Missing ureteral obstruction in a cat with a small bladder.
- Diagnosing UTI from pyuria without urine culture.
- Assuming normal creatinine excludes early AKI.
- Mistaking fluid-induced haemodilution for renal recovery.
- Missing hypertension and retinal injury.
- Ignoring medication and toxin history.
- Giving nephrotoxic drugs before collecting essential samples or assessing renal status.
11. TREATMENT PROTOCOL
Treatment priorities
- Stabilize ABCs.
- Correct hypovolaemia and hypotension.
- Stop nephrotoxins.
- Relieve obstruction or repair urine leakage.
- Treat hyperkalaemia, dangerous acidosis, and fluid overload.
- Identify and treat the cause.
- Provide antiemesis, nutrition, analgesia, and intensive monitoring.
- Refer early for ureteral intervention or renal replacement therapy when indicated.
A. Mild AKI
Typical profile: non-oliguric, stable perfusion, mild azotaemia, no dangerous electrolyte derangement.
- Hospitalize or closely supervise depending on cause and trend.
- Stop nephrotoxins.
- Address dehydration with individualized balanced isotonic crystalloid therapy.
- Monitor creatinine, electrolytes, body weight, urine output, and BP.
- Treat nausea/pain.
- Investigate cause: culture, imaging, infectious/toxin testing as indicated.
- Ensure enteral nutrition as soon as vomiting is controlled.
B. Moderate AKI
Typical profile: progressive azotaemia, vomiting/anorexia, electrolyte changes, significant dehydration, or suspected infection/toxin.
- Hospitalize with strict input-output charting.
- IV fluid plan tailored to deficit, ongoing losses, urine output, and cardiovascular tolerance.
- Urinary catheter if necessary for accurate output, using aseptic technique and removing as soon as practical.
- Urine culture before antibiotics when feasible.
- Serial electrolyte, acid-base, BP, body weight assessments.
- Early referral discussion if creatinine rises despite correction of perfusion, oliguria develops, or ureteral disease is suspected.
C. Severe/critical AKI
Typical profile: oliguria/anuria, severe hyperkalaemia/acidosis, pulmonary oedema, severe uraemia, hypertension, neurological signs, obstruction, septic shock.
- ICU-level care.
- ECG and frequent blood gas/electrolyte monitoring.
- Treat hyperkalaemic cardiotoxicity immediately when ECG changes/bradyarrhythmia are present.
- Avoid blind high-rate fluid administration.
- Relieve postrenal obstruction urgently.
- Consult/referral for intermittent haemodialysis, continuous renal replacement therapy, or peritoneal dialysis early rather than after prolonged deterioration.
D. Emergency/ICU management: first-hour checklist
- Oxygen if hypoxaemic or in respiratory distress.
- IV access, blood pressure, ECG if indicated.
- Bedside electrolytes/blood gas/glucose.
- Palpate bladder, POCUS abdomen and lungs.
- Controlled isotonic crystalloid boluses only if hypovolaemic.
- Hyperkalaemia protocol if indicated.
- Urinary catheter/decompression if urethral obstruction.
- Abdominocentesis if uroabdomen suspected.
- Analgesia and antiemetic therapy.
- Infection control precautions when leptospirosis is possible.
Drug table: standard reference-style doses
These are educational reference ranges, not automatic prescriptions. Choose therapy from the patient’s perfusion, ECG, potassium, acid-base status, urine output, cause, concurrent disease, local formulary, and monitoring capacity.
| Drug | Class/indication | Reference dose | Key cautions/monitoring |
|---|
| Maropitant | NK1 antiemetic | 1 mg/kg IV or SC q24h | Use for vomiting/nausea. Does not replace investigation of GI obstruction or pancreatitis. Monitor comfort at injection |
| Ondansetron | 5-HT3 antiemetic | 0.1-0.2 mg/kg IV q8-12h | Useful for refractory nausea. Consider QT risk and drug interactions in predisposed patients |
| Metoclopramide | Prokinetic/antiemetic | 1-2 mg/kg/day IV CRI | Avoid if GI obstruction/perforation suspected; may cause agitation or dysphoria |
| Buprenorphine | Opioid analgesic | 0.01-0.02 mg/kg IV, IM, or transmucosally q6-8h | Good feline option. Sedation, dysphoria, reduced GI motility possible |
| Methadone | Opioid analgesic | 0.1-0.3 mg/kg IV/IM q4-6h | Dose to effect. Monitor sedation, ventilation, dysphoria |
| Calcium gluconate 10% | Cardiac membrane stabilizer in hyperkalaemia | 50-100 mg/kg IV slowly over 10-20 min with ECG monitoring | Does not lower potassium. Stop if bradyarrhythmia worsens; avoid extravasation |
| Regular insulin plus dextrose | Shifts potassium intracellularly | Regular insulin 0.1 U/kg IV, paired with dextrose per protocol | Check glucose every 1-2 hours initially. Hypoglycaemia is the major risk |
| Terbutaline | Beta-2 agonist, potassium shift | 0.01 mg/kg SC | May cause tachycardia, tremors. Adjunct, not definitive therapy |
| Furosemide | Loop diuretic | A cautious diagnostic/therapeutic trial may be considered only after euvolaemia and obstruction are addressed | It does not repair AKI or improve renal recovery. Monitor BP, volume, electrolytes, urine output. Avoid escalating repeatedly in anuric, overloaded patients |
| Ampicillin/amoxicillin | Antibiotic when bacterial infection is supported/suspected | Selection and dose should follow culture, site, severity, and renal adjustment | Not indicated for uncomplicated sterile AKI. Obtain culture first when possible |
| Doxycycline | Used to eliminate renal carriage after initial treatment for canine leptospirosis | 5 mg/kg PO q12h for 14 days is a commonly used protocol | GI adverse effects; administer with water/food. Use after patient can tolerate oral medication and follow local infectious-disease guidance |
Drugs usually avoided or used only with strong justification
- NSAIDs: avoid in suspected AKI.
- Aminoglycosides: avoid unless no safer option and use therapeutic drug monitoring.
- ACE inhibitors/ARBs: do not start during unstable AKI/hypotension.
- Mannitol: not routine; can worsen fluid overload and is inappropriate in anuric/fluid-overloaded patients.
- Dopamine “renal-dose”: do not use simply to “improve renal perfusion.” It has not shown reliable renal-protective benefit.
- Empirical antibiotics: do not prescribe merely because AKI is severe.
A current review emphasizes tailored fluids, urine output and BP surveillance, nutritional support, and cause-specific treatment rather than forced diuresis. See
AKI management review.
12. FLUID THERAPY
The principle
Fluid therapy has three distinct aims:
- Restore intravascular volume if hypovolaemic.
- Correct interstitial dehydration deficit.
- Replace maintenance needs plus measured ongoing losses.
After those goals are met, target near-zero fluid balance: input should approximately match output. The current AKI literature stresses early correction of true hypovolaemia while preventing iatrogenic overload in low-output patients.
Fluid selection
- Balanced isotonic crystalloids are appropriate in many AKI patients.
- 0.9% saline may be selected when clinically indicated, but excessive chloride exposure can worsen hyperchloraemic acidosis.
- Choice should be based on sodium, chloride, acid-base status, concurrent disease, and availability.
- Do not avoid balanced crystalloid solely because it contains a small amount of potassium. The potassium concentration in common balanced fluids is usually far lower than the patient’s plasma potassium and does not generally drive emergency hyperkalaemia management.
- Add potassium only after documented need and careful calculation. Never add potassium to fluids in a hyperkalaemic or anuric patient.
Shock resuscitation: titrated, not blind
In AKI or suspected AKI, give smaller aliquots and reassess:
- Dog: 10-15 mL/kg isotonic crystalloid over 10-15 minutes.
- Cat: 5 mL/kg over 10-15 minutes.
Reassess after each bolus:
- HR/rhythm and pulse quality
- Mentation
- BP/MAP
- CRT and mucous membranes
- Lung sounds/POCUS B-lines
- Respiratory effort/SpO₂
- Body weight
- Urine output
If hypotension persists after volume status is reasonable, investigate vasodilation/sepsis/cardiac dysfunction and consider vasoactive support in ICU rather than repeated fluid boluses.
Deficit calculation
Fluid deficit (mL) = body weight (kg) × dehydration fraction × 1000
Example: 10 kg dog, estimated 8% dehydrated
10 × 0.08 × 1000 = 800 mL deficit
Replace over a clinically appropriate period, commonly over about 6-12 hours if cardiovascularly tolerated, while counting all fluids already administered.
Maintenance
A practical hospitalized starting estimate is often about 2-3 mL/kg/hr, then adjust. It is not a mandatory rate.
Example maintenance estimates
| Patient | At 2 mL/kg/hr | At 3 mL/kg/hr |
|---|
| 2 kg cat | 4 mL/hr | 6 mL/hr |
| 5 kg cat | 10 mL/hr | 15 mL/hr |
| 10 kg dog | 20 mL/hr | 30 mL/hr |
| 20 kg dog | 40 mL/hr | 60 mL/hr |
| 30 kg dog | 60 mL/hr | 90 mL/hr |
For an oliguric/anuric patient, do not automatically give full maintenance. Base fluid delivery on measured losses, urine output, insensible losses, nutrition, electrolyte needs, and frequent reassessment.
Ongoing loss replacement
Ongoing loss replacement = measured urine + vomitus + diarrhoea + drain losses, adjusted by clinical reassessment.
Example: 10 kg dog after stabilization:
- Urine output: 0.8 mL/kg/hr = 8 mL/hr
- Estimated maintenance: 20 mL/hr
- Vomiting: 20 mL over 4 hours = 5 mL/hr
Estimated hourly requirement: 8 + 20 + 5 = 33 mL/hr, then reassess frequently.
If this dog is fluid overloaded or oliguric, this formula must be revised downward and referral considered.
Urine output targets
- Expected normal urine output in hospitalized patients is often roughly 1-2 mL/kg/hr.
- Persistent oliguria is concerning. Confirm catheter patency, bladder emptying, hydration, BP, obstruction status, and measurement accuracy before adding drugs.
- Persistent anuria or very low urine output despite appropriate optimization requires urgent reassessment and often referral.
Stop or reduce fluids when
- Deficits are corrected.
- BP/perfusion is adequate.
- Urine output is low and body weight is increasing.
- New tachypnoea, crackles, pleural effusion, pulmonary oedema, or increased B-lines develop.
- Peripheral oedema, chemosis, serous nasal discharge, or worsening hypertension occurs.
- PCV/TS falls from dilution without clinical improvement.
Fluid overload signs
- Rapid weight gain
- Increased RR/effort
- Crackles, B-lines, pulmonary oedema
- Pleural effusion
- Chemosis, peripheral oedema
- Worsening hypertension
- Serous nasal discharge
- New oxygen requirement
13. DOSE CALCULATIONS
Formula
Dose (mg) = body weight (kg) × dose (mg/kg)
Worked example: maropitant 1 mg/kg
This is an example of arithmetic, not an instruction to use maropitant in every patient.
| Patient | Calculation | Dose |
|---|
| 2 kg cat | 2 × 1 mg/kg | 2 mg |
| 5 kg cat | 5 × 1 mg/kg | 5 mg |
| 10 kg dog | 10 × 1 mg/kg | 10 mg |
| 20 kg dog | 20 × 1 mg/kg | 20 mg |
| 30 kg dog | 30 × 1 mg/kg | 30 mg |
Worked example: buprenorphine 0.02 mg/kg
| Patient | Calculation | Dose |
|---|
| 2 kg cat | 2 × 0.02 | 0.04 mg |
| 5 kg cat | 5 × 0.02 | 0.10 mg |
| 10 kg dog | 10 × 0.02 | 0.20 mg |
| 20 kg dog | 20 × 0.02 | 0.40 mg |
| 30 kg dog | 30 × 0.02 | 0.60 mg |
Converting mg to mL
Volume (mL) = required dose (mg) ÷ product concentration (mg/mL)
I have intentionally not converted these doses to mL because injectable and oral product concentrations vary by country and manufacturer. Use the exact concentration printed on your product label.
Example format:
- Required dose: 10 mg
- Label concentration: ___ mg/mL
- Volume: 10 ÷ ___ = ___ mL
For a real patient, provide the drug name, formulation, and label concentration, and the calculation can be checked exactly.
14. SUPPORTIVE CARE
Nutrition
- Do not prolong starvation because of nausea alone.
- Control vomiting/nausea first, then start early enteral nutrition if safe.
- In acute critical illness, prioritize adequate calories and protein rather than automatically imposing severe protein restriction.
- Use feeding tubes when the GI tract is usable and voluntary intake is absent.
- In cats, avoid prolonged anorexia because hepatic lipidosis can develop.
- Renal therapeutic diets may be useful later, especially if CKD persists, but acute nutritional decisions must be individualized.
Antiemetics
Use maropitant, ondansetron, or metoclopramide according to clinical signs and contraindications. Reassess for GI obstruction, pancreatitis, uraemia, and drug adverse effects.
Analgesia
- Prefer opioids titrated to effect.
- Avoid NSAIDs in AKI.
- Treat renal/ureteral pain, abdominal pain, and catheter-associated discomfort.
Gastroprotection
- Do not give acid suppressants automatically to every uraemic patient.
- Consider gastroprotective treatment for documented or strongly suspected GI ulceration, haematemesis, melaena, severe reflux, or other specific indication.
- Sucralfate can interfere with absorption of other drugs, so separate administration times.
Antibiotics
Only when there is:
- Pyelonephritis/UTI supported by culture or strong clinical evidence
- Leptospirosis or credible bacterial infectious cause
- Sepsis/bacteraemia
- An infected urinary obstruction or urinary tract instrumentation complication
Electrolytes/vitamins
- Correct potassium, magnesium, phosphate, sodium, calcium, and acid-base abnormalities based on measured values.
- Do not add potassium “routinely.”
- Phosphate binders are more relevant once enteral feeding occurs and hyperphosphataemia persists; they do not replace treating severe AKI or dialysis.
- B vitamins may be considered in prolonged polyuric losses, but are not an AKI cure.
Oxygen
Indicated for hypoxaemia, dyspnoea, pulmonary oedema, severe anaemia, or shock.
Blood products
Indicated for clinically important haemorrhage, haemolysis, or severe symptomatic anaemia, not merely a mildly decreased PCV.
Nursing care
- Accurate intake-output chart
- Closed urine collection if catheterized
- Catheter asepsis and daily need assessment
- Turn recumbent patients regularly
- Oral care for uraemic ulcers
- Anti-nausea feeding plan
- Daily weight, sometimes 2-4 times daily in unstable cases
- Barrier nursing/PPE for suspected leptospirosis
15. ANTIBIOTIC STEWARDSHIP
When antibiotics are truly indicated
- Positive urine culture with compatible pyelonephritis/UTI signs
- Septic patient
- Leptospirosis
- Infected obstruction
- Bacterial focus outside the urinary tract causing AKI
Best practice
- Obtain urine by cystocentesis for culture before antibiotics when patient stability allows.
- Choose empirical therapy based on illness severity, likely site, local resistance, and renal safety.
- Modify treatment promptly using culture/susceptibility results.
- Use the narrowest effective drug.
- Review renal dose adjustment and avoid nephrotoxic choices when alternatives exist.
- Do not diagnose pyelonephritis from pyuria alone.
- Repeat culture when clinically indicated, especially if response is poor or infection is complicated.
Avoid
- “Preventive” antibiotics for sterile AKI.
- Prolonged antibiotics without culture reassessment.
- Aminoglycosides in unstable AKI unless there is no viable alternative and specialist-level monitoring is available.
16. PROGNOSIS
Prognosis depends more on cause, response, urine output, complications, and access to renal replacement therapy than on a single creatinine concentration.
Better prognostic indicators
- Rapid correction of a prerenal cause
- Relief of obstruction before severe prolonged injury
- Improving creatinine trend
- Return of appropriate urine output
- Stable BP and electrolytes
- Controlled infection/toxin exposure
- Ability to eat and tolerate enteral nutrition
- No severe comorbidity
Poor prognostic indicators
- Persistent anuria/oliguria
- Worsening azotaemia despite corrected perfusion
- Refractory hyperkalaemia, acidosis, fluid overload, or hypertension
- Severe systemic sepsis/MODS
- Severe nephrotoxic injury
- Advanced acute-on-CKD
- Delayed presentation after lily or ethylene glycol exposure
- Inability to access obstruction relief or renal replacement therapy when indicated
Reported survival varies widely, roughly
38%-66% in mixed AKI populations, reflecting differing causes, severity, referral patterns, and euthanasia decisions. See the
clinical AKI review.
Refer urgently when
- Suspected ureteral obstruction
- Persistent oliguria/anuria
- Refractory hyperkalaemia/acidosis
- Fluid overload
- Creatinine is rising in an appropriately hydrated patient
- Need for haemodialysis/CRRT/peritoneal dialysis
- Severe hypertension, pulmonary oedema, or neurological uraemia
17. MONITORING SHEET
| Parameter | Mild/stable AKI | Moderate AKI | Severe/ICU AKI |
|---|
| TPR, mentation, pain | Every 4-6 h | Every 2-4 h | Continuous/at least hourly |
| BP | Every 6-12 h | Every 2-4 h | Continuous or every 1-2 h |
| ECG | If electrolyte risk | Intermittent if K abnormal | Continuous if significant hyperkalaemia/arrhythmia |
| SpO₂/RR/effort | Every 4-6 h | Every 2-4 h | Continuous if unstable or overloaded |
| Urine output | Every 4-6 h | Hourly where possible | Hourly |
| Fluid input/output | Every 4-6 h | Hourly to 2-hourly | Hourly |
| Body weight | Daily | 2 times daily | Every 4-8 h if fluid balance is precarious |
| CBC | Daily or as indicated | Daily | 12-24 h, or sooner if bleeding/sepsis |
| Electrolytes, glucose, blood gas | Daily to 12-hourly | Every 6-12 h | Every 2-6 h during instability |
| BUN/creatinine/phosphorus | Daily | Every 12-24 h | Every 12-24 h, trend-based |
| UA/culture | At baseline; repeat if indicated | Baseline + response driven | Baseline, then cause-driven |
| Lung ultrasound/radiographs | If respiratory change | If fluid intolerance suspected | Serial as clinically indicated |
18. COMMON CLINICAL MISTAKES
- Giving large-volume fluids to every azotaemic patient.
- Failing to document urine output.
- Mistaking oliguria from obstruction for intrinsic renal failure.
- Not palpating the bladder or using POCUS.
- Missing ureteral obstruction in cats because the bladder is small.
- Treating hyperkalaemia without ECG assessment when available.
- Giving calcium gluconate and assuming potassium has been corrected.
- Using furosemide repeatedly instead of reassessing perfusion, obstruction, and referral needs.
- Starting antibiotics without obtaining culture in a stable patient.
- Missing leptospirosis and exposing staff or other animals.
- Assuming a single normal creatinine excludes AKI.
- Failing to stop NSAIDs, aminoglycosides, and other nephrotoxins.
- Ignoring blood pressure and fundic examination.
- Underfeeding anorectic cats.
- Calling a patient “recovered” because creatinine briefly falls after haemodilution.
What you may miss if you focus only on AKI
- Addisonian crisis
- Uroabdomen
- Pancreatitis/sepsis causing renal hypoperfusion
- Hypertensive emergency
- Cardiac disease limiting fluids
- Acute-on-CKD
- Pyometra
- Hypercalcaemia
- Severe toxic exposure needing antidotal therapy or decontamination
- Obstructive uropathy requiring intervention, not more medical therapy
19. RED FLAGS
Immediate hospitalization
- Persistent vomiting/anorexia with azotaemia
- Oliguria or uncertain urine production
- AKI with dehydration, pain, fever, or toxin exposure
- Suspected pyelonephritis or leptospirosis
- Progressive creatinine or phosphorus increase
Emergency stabilization
- Bradycardia, weakness, or ECG changes with hyperkalaemia
- Hypotension/shock
- Urethral obstruction
- Suspected uroabdomen
- Any cat with possible lily ingestion
- Severe acidosis
- Dyspnoea or suspected fluid overload
- Seizures, coma, severe uraemic encephalopathy
ICU/referral
- Persistent urine output below approximately 0.3 mL/kg/hr for over 6 hours despite appropriate medical optimization
- Anuria
- Uncontrolled hyperkalaemia/acidosis
- Refractory fluid overload
- Rising creatinine despite corrected hydration/perfusion
- Suspected bilateral ureteral obstruction
- Need for dialysis or advanced interventional urology
Blood transfusion
- Active significant haemorrhage
- Severe symptomatic anaemia with poor oxygen delivery
- Not solely because a patient has AKI or mild non-regenerative anaemia
Surgery/interventional procedure
- Urethral obstruction not medically relieved
- Uroabdomen
- Ureteral obstruction requiring stent or subcutaneous ureteral bypass
- Selected stones, strictures, masses, trauma
20. CASE SIMULATION
Case: do not scroll for an answer because none is provided yet
Signalment
Milo, 7-year-old neutered male domestic shorthair cat, 4.6 kg.
History
Presented for 36 hours of hiding, anorexia, intermittent vomiting, and reduced activity. The owner has seen small urine clumps but is uncertain whether Milo is urinating normally. No known lily exposure. Indoor-outdoor access. A previous urinary obstruction occurred 3 years ago. No current medication. The owner reports increased water intake over the preceding month.
Clinical examination
- Quiet but responsive
- Temperature: 37.4°C
- HR: 156 bpm, regular
- RR: 34/min, mildly increased but unlaboured
- BP: 178 mmHg systolic, repeated after acclimation
- Mucous membranes: tacky, pink; CRT 2 sec
- Estimated dehydration: 6%
- Kidneys palpably uncomfortable; left kidney seems enlarged
- Bladder: small to moderately sized, non-turgid
- Mild oral halitosis, no ulcers
- No heart murmur; lung sounds clear
CBC
| Test | Result |
|---|
| PCV | 35% |
| Hb | 11.8 g/dL |
| RBC | 7.1 × 10¹²/L |
| MCV | 49 fL |
| MCHC | 33.5 g/dL |
| WBC | 18.9 × 10⁹/L |
| Neutrophils | 15.7 × 10⁹/L |
| Bands | 0.6 × 10⁹/L |
| Lymphocytes | 1.2 × 10⁹/L |
| Monocytes | 1.1 × 10⁹/L |
| Platelets | Adequate on smear |
Biochemistry and blood gas
| Test | Result |
|---|
| BUN | 96 mg/dL |
| Creatinine | 6.2 mg/dL |
| SDMA | 52 µg/dL |
| Phosphorus | 9.8 mg/dL |
| Potassium | 5.9 mmol/L |
| Sodium | 150 mmol/L |
| Chloride | 113 mmol/L |
| Total calcium | 9.1 mg/dL |
| Albumin | 3.5 g/dL |
| Glucose | 127 mg/dL |
| ALT | 68 U/L |
| Venous pH | 7.27 |
| HCO₃⁻ | 15 mmol/L |
| Lactate | 2.4 mmol/L |
Urinalysis
Cystocentesis sample before antimicrobials:
- USG: 1.018
- Protein: 2+
- Blood: 1+
- Glucose: negative
- Ketones: negative
- Sediment: 10-15 WBC/hpf, 5-10 RBC/hpf, rare granular casts, no visible bacteria
- Urine submitted for culture and susceptibility
Imaging
Abdominal ultrasound:
- Left renal pelvis: 8 mm dilation
- Proximal left ureter mildly dilated
- 2 mm hyperechoic focus with distal acoustic shadowing near proximal ureter
- Right renal pelvis: 2 mm dilation
- Both kidneys mildly irregular; left kidney enlarged
- Urinary bladder small, no obvious urolith
- No free abdominal fluid
Your tasks
- Identify the major problem list.
- List and prioritize differentials.
- Interpret the CBC.
- Interpret the biochemistry and blood gas.
- Select further tests and explain why.
- Give your presumptive diagnosis.
- Create an emergency and ongoing treatment plan.
- Calculate doses for antiemetic, analgesic, and any indicated hyperkalaemia treatment.
- Create a monitoring plan for the first 24 hours.
- Give prognosis and referral recommendation.
Reply with your reasoning in numbered sections. I will assess it like a senior clinician, identify unsafe assumptions, and provide corrections.
21. QUICK CLINICAL ALGORITHM
AZOTAEMIC / VOMITING / OLIGURIC DOG OR CAT
|
v
1. TRIAGE ABCs
- BP, ECG if K high/bradycardia, glucose, blood gas, oxygen if needed
|
v
2. IS THERE AN IMMEDIATE POSTRENAL EMERGENCY?
- Palpate bladder, POCUS, assess for uroabdomen
- Obstruction or urine leak -> decompress/repair/referral
|
v
3. IS THE PATIENT HYPOVOLAEMIC OR HYPOTENSIVE?
- Small crystalloid bolus, reassess after each aliquot
- Correct deficit carefully
|
v
4. MINIMUM DATABASE
- CBC, chemistry, electrolytes, phosphorus, UA/culture, BP
- Urine output, imaging, serial creatinine/SDMA
|
v
5. CLASSIFY
- Prerenal, intrinsic renal, postrenal, or mixed
- Identify cause: toxin, infection, ischaemia, obstruction, acute-on-CKD
|
v
6. TREAT COMPLICATIONS
- Hyperkalaemia/ECG changes
- Acidosis
- Nausea, pain, hypertension, fluid overload
|
v
7. TARGETED THERAPY
- Antidote/decontamination, antimicrobials only if indicated,
relieve obstruction, treat sepsis or leptospirosis
|
v
8. MONITOR HOURLY IF CRITICAL
- Urine output, inputs, BW, BP, ECG, RR/lung status, electrolytes
|
v
9. REFER EARLY
- Anuria/oliguria, ureteral obstruction, rising creatinine,
refractory K/acidosis/overload, dialysis need
|
v
10. DISCHARGE ONLY WHEN
- Stable hydration, controlled vomiting, safe urine output,
cause addressed, owner can monitor, recheck plan in place
22. MEMORY TOOL
Ten key points
- AKI is sudden renal dysfunction, not simply increased creatinine.
- Always consider prerenal, intrinsic renal, and postrenal causes.
- A normal creatinine does not exclude early AKI.
- Urine output is a core vital parameter.
- Correct hypovolaemia, but do not force fluids in oliguria/anuria.
- Urethral and ureteral obstruction are time-sensitive emergencies.
- Hyperkalaemia can kill by arrhythmia.
- Cats with suspected lily exposure require immediate action.
- Culture urine before antibiotics when practical.
- Early referral can change outcome when dialysis or ureteral intervention is needed.
Ten important drug facts
- NSAIDs are generally contraindicated in suspected AKI.
- Calcium gluconate stabilizes myocardium but does not lower potassium.
- Insulin plus dextrose lowers serum potassium temporarily by intracellular shifting.
- Furosemide does not cure AKI and should not replace reassessment/referral.
- “Renal-dose dopamine” is not a renal-protective treatment.
- Maropitant controls vomiting but may not fully control nausea.
- Ondansetron is useful for persistent nausea but consider QT risk.
- Opioids are preferred analgesics over NSAIDs in AKI.
- Avoid aminoglycosides where safer alternatives exist.
- Antibiotics require a bacterial indication, culture plan, and renal dosing review.
Ten diagnostic clues
- Large painful bladder plus hyperkalaemia: think urethral obstruction.
- Small bladder plus azotaemia in a cat: do not miss ureteral obstruction.
- Abdominal fluid creatinine/potassium above serum: think uroabdomen.
- Fever, renal pain, pyuria: consider pyelonephritis.
- AKI plus hepatic/pulmonary signs in a dog: consider leptospirosis.
- Severe acidosis with compatible exposure: consider ethylene glycol.
- Azotaemia resolving after rehydration: prerenal component likely.
- Small irregular kidneys with anaemia: CKD or acute-on-CKD likely.
- Rising weight and tachypnoea during fluids: fluid overload until proven otherwise.
- Hyperkalaemia plus bradycardia: ECG immediately.
Ten common mistakes
- Not measuring urine output.
- Giving maintenance fluids automatically to anuric patients.
- Missing a postrenal cause.
- Delaying ultrasound in a possible ureteral obstruction.
- Treating pyuria without culture.
- Failing to ask about toxins and medications.
- Ignoring blood pressure.
- Using nephrotoxic drugs in a high-risk patient.
- Waiting too long to discuss dialysis/referral.
- Interpreting one lab value rather than serial trends.
Ten high-yield MCQs
-
In an AKI patient with bradycardia and ECG changes from hyperkalaemia, which treatment stabilizes cardiac membranes?
Answer: Calcium gluconate.
-
Does calcium gluconate lower serum potassium?
Answer: No.
-
What is the first major diagnostic category to exclude in an azotaemic cat with a small bladder?
Answer: Ureteral obstruction.
-
What is the most useful routine measurement for guiding fluids in hospitalized AKI?
Answer: Accurate urine output plus body weight and input-output balance.
-
Which drug class is generally avoided in AKI?
Answer: NSAIDs.
-
Which sample should ideally be collected before starting antibiotics for suspected pyelonephritis?
Answer: Urine culture, preferably cystocentesis sample.
-
Can a patient have early AKI with normal creatinine?
Answer: Yes.
-
What is the key treatment for postrenal azotaemia from obstruction?
Answer: Urgent relief of obstruction.
-
What is a classic serious toxin exposure causing AKI in cats?
Answer: Lilies.
-
What is the fluid goal after deficits have been corrected?
Answer: Approximately zero fluid balance, matching input to measured/estimated output.
Five clinical pearls
- “No urine” is a diagnosis problem before it is a diuretic problem. Confirm catheter patency, obstruction, volume status, BP, and renal perfusion first.
- Fluid overload is an iatrogenic emergency. Daily or frequent body weight is often more informative than skin turgor.
- Ureteral obstruction can be subtle in cats. A small bladder does not make obstruction unlikely.
- Treat the ECG and perfusion, not just numbers. Severe hyperkalaemia can be fatal before a full diagnostic work-up is complete.
- Creatinine is delayed and muscle-dependent. Serial trends, USG, urine output, SDMA, and context are stronger than one isolated result.
Recent veterinary literature supports individualized fluid/electrolyte therapy and early use of renal replacement therapy when medical control fails. The recent systematic review of stem-cell approaches in canine/feline renal disease does
not justify routine stem-cell therapy for emergency AKI at this stage:
2024 review, PMID 38851051.